Close Menu

This article has been corrected to make clear that Genomic Health expects to make IVD products available in France and Germany in 2020.

NEW YORK (GenomeWeb) – Following a year of major milestones, Genomic Health CEO Kim Popovits said that the company expects to sustain and grow its momentum in 2019 with a focus on increasing adoption of its core breast cancer product in the US, pushing international expansions, and continuing to diversify its test menu.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.